| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_deff0ab87e07d714dcf3d03223972069 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0212
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-02 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C279-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 |
| filingDate |
1989-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87a8faa7903fd83191627314848f32e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b8ac5d31ac59b900c48f89e50129afb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a061a038c273a57654aafd1c9d32fe6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc06cf06c9c900e326b7c3ed8d528ff2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3218fe73caa79bdf3ecd91fb1ccd753c |
| publicationDate |
1990-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0375058-A2 |
| titleOfInvention |
New retro-inverso analogues of trymopentin, the method for their synthesis and their use in the preparation of pharmaceutical compositions |
| abstract |
New analogues of thymopentin (TP5) and of its tetrapeptide fragment (TP5¹⁻⁴) containing two non-contiguous retro-inverted bonds in the peptide chain are described. n The new compounds, of general formula (I)n where R is hydrogen or an acyl radical, nand R¹ is an -OR² group or ann group where R² is a hydrogen atom or a hydrocarbon radical, and R³ is a hydrogen atom or a hydroxyl group, nand the corresponding pharmaceutically acceptable salts of acid or basic addition, possess immunomodulating activity. |
| priorityDate |
1988-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |